Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase

ClinicalTrials.gov ID: NCT00340834

Public ClinicalTrials.gov record NCT00340834. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 11:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-month Double-blind, Randomized, Multicenter, Active-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5 mg and 1.25 mg Fingolimod (FTY720) Administered Orally Once Daily Versus Interferon ß-1a (Avonex) Administered im Once Weekly in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study assessed the safety, tolerability, and efficacy of 2 doses of oral fingolimod versus interferon β-1a to reduce the frequency of relapses in patients with relapsing-remitting multiple sclerosis.

Study identification

NCT ID
NCT00340834
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis
Industry
Enrollment
1,292 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2006 (Type not available)
Primary completion
Jul 2011 (Actual)
Completion
Jul 2011 (Actual)
Last update posted
Sep 21, 2017

2006 – 2011

United States locations

U.S. sites
35
U.S. states
17
U.S. cities
34
Facility City State ZIP Site status
North Central Neurology Associates, PC, 1809 Kress Street Cullman Alabama 35058 —
Barrow Neurological Institute Phoenix Arizona 85013 —
The Neurology Center, 3907 Waring Road, Suite 3 Oceanside California 92056 —
Associated Neurologists, PC, 69 Sand Pit Road, Suite 300 Danbury Connecticut 06810 —
Associated Neurologists of Southern CT, PC, 75 Kings Highway Cutoff Fairfield Connecticut 06824 —
Yale University Multiple Sclerosis Center New Haven Connecticut 06510 —
University of Florida Health Science Center Jacksonville Florida 32209 —
Neurology Associates, PA, 301 N. Maitland Avenue, Suite A1 Maitland Florida 32751 —
University of Miami, Department of Neurology Miami Florida 33136 —
Neurological Associates Pompano Beach Florida 33060 —
Roskamp Institute, 2040 Whitfield Ave. Sarasota Florida 34243 —
AMO Corporation Tallahassee Florida 32308 —
Axiom Clinical Research of Florida, 2919 Swann Avenue, Suite 401 Tampa Florida 33609 —
University of South Florida, Department of Neurology Tampa Florida 33612 —
The MS Center of Vero Beach Vero Beach Florida 32960 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Mid America Neuroscience Institute, 8550 Marshall Drive, Suite 100 Lenexa Kansas 66214 —
University Physician Group, #1 Barnes-Jewish Hospital Plaza, Suite 16304 St Louis Missouri 63110 —
Neuroscience and Spine Center Charlotte North Carolina 28207 —
Raleigh Neurology Associates, 1540 Sunday Drive Raleigh North Carolina 27607 —
Neurology & Neuroscience Associates, Inc Akron Ohio 44302 —
Northern Ohio Neuroscience, LLC Bellevue Ohio 44811 —
Cleveland Clinic Cleveland Ohio 44195 —
Oregon Neurology Tualatin Oregon 97062 —
University of Pittsburgh, Department of Neurology Pittsburgh Pennsylvania 15213 —
Absher Neurology, 274-A Commonwealth Drive Greenville South Carolina 29615 —
Mountain Empire Neurological Associates, PC, 3183 West State Street, Suite 1201 Bristol Tennessee 37620 —
Advanced Neurosciences Institute Franklin Tennessee 37064 —
Baylor College of Medicine Houston Texas 77030 —
Private Practice, 3815 23rd Street Lubbock Texas 79410 —
Integra Clinical Research, 4242 Medical Drive, Suite 6100 San Antonio Texas 78229 —
Swedish Neuroscience Institute Seattle Washington 98122 —
Rockwood Clinic, P.S. Spokane Washington 99202 —
West Virginia University Health Associates Morgantown West Virginia 26506 —
Center for Neurological Disorders - Aurora St. Luke's Med Center Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 135 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00340834, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 21, 2017 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00340834 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →